Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators

Details for Australian Patent Application No. 2011223566 (hide)

Owner Janssen Pharmaceutica NV

Inventors Player, Mark R.; Calvo, Raul; Chen, Jinsheng; Meegalla, Sanath; Parks, Daniel; Parsons, William; Ballentine, Scott; Branum, Shawn

Agent Shelston IP

Pub. Number AU-A-2011223566

PCT Pub. Number WO2011/109587

Priority 61/310,870 05.03.10 US

Filing date 3 March 2011

Wipo publication date 9 September 2011

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437

A61K 31/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/52

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 473/00 Heterocyclic compounds containing purine ring systems

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/109587 Priority application(s): WO2011/109587

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223570-Portable therapeutic gas dispensing device

2011223563-Modulation of intracellular signaling